Luskin A, Griffin NM, Wagele-Steffen A, et al. Decreased exacerbations and hospitalizations in adolescents enrolled in PROSPERO (Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab). ATS 2017, abstract A5104.
Toegang tot zorg bij vroegstadium longkanker in Europa moet beter
mrt 2024 | Immuuntherapie, Longoncologie